QQ客服 官方微博 反馈留言

	Compound F779-0434 causes synthetic lethality in BRCA2-deficient cancer cells by disrupting RAD52–ssDNA association
	Li, J; Yang, QY; Zhang, Y; Huang, KJ; Sun, R; Zhao, Q
刊名	RSC Advances
	2018
卷号	Vol.8 No.34页码:18859-18869
ISSN号	2046-2069
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1868608
专题	四川大学
作者单位	1.Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China 2.Sichuan Univ, Key Lab Bioresources, Minist Educ, Chengdu 610064, Sichuan, Peoples R China 3.Chengdu Univ, Sch Med, Chengdu 610106, Sichuan, Peoples R China 4.Chengdu Univ, Coll Pharm & Biol Engn, Chengdu 610106, Sichuan, Peoples R China 5.Chengdu Univ, Sichuan Ind Inst Antibiot, Chengdu 610052, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Li, J,Yang, QY,Zhang, Y,et al. Compound F779-0434 causes synthetic lethality in BRCA2-deficient cancer cells by disrupting RAD52–ssDNA association[J]. RSC Advances,2018,Vol.8 No.34:18859-18869.
APA	Li, J,Yang, QY,Zhang, Y,Huang, KJ,Sun, R,&Zhao, Q.(2018).Compound F779-0434 causes synthetic lethality in BRCA2-deficient cancer cells by disrupting RAD52–ssDNA association.RSC Advances,Vol.8 No.34,18859-18869.
MLA	Li, J,et al."Compound F779-0434 causes synthetic lethality in BRCA2-deficient cancer cells by disrupting RAD52–ssDNA association".RSC Advances Vol.8 No.34(2018):18859-18869.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。